The functional and histological liver alterations induced by amiodarone treatment have been
well known for some time and often consist in isolated increases in transaminase levels …

We describe an interesting case of a woman with decompensated cirrhosis, ischaemic heart
disease and prolonged QT interval, who developed a new-onset atrial fibrillation. During …

We report a patient with classical features of amiodarone hepatotoxicity who died of
progressive liver failure. Throughout the course of his illness, he had epigastric pain …

Cholestasis has been reported as a rare presentation among patients with severe liver injury
secondary to amiodarone hepatic toxicity. We report an unusual case of amiodarone …

A few cases of alcohol-like chronic liver disease have recently been described in patients on
high daily doses of amiodarone (400–600 mg) for 5–24 months. We report here 3 cases in …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Amiodarone remains the agent of choice for the 80 mmHg and clinical and radiological
evidence of management of atrial fibrillation in unstable patients fluid overload. He was …

A patient with acute changes suggesting acute hepatitis after parenteral amiodarone
administration is described. A 77‐year‐old man with previous myocardial infarction was …

Abstract Amiodarone [2-butyl-3-(3′, 5′-diiodo-4'α-diethylaminoethoxybenzoyl)-
benzofuran](AMD), a class III antiarrhythmic drug, is known to cause idiosyncratic …

Two fatal cases of amiodarone-induced acute, confluent, necrotic hepatitis are described.
The patients, aged 28 and 60, had received a high loading dose of amiodarone. After the …